The Colorado Consortium for Prescription Drug Abuse Prevention works with the Colorado General Assembly to provide reliable information about the prescription drug use and misuse and possible policies and regulations.
2020 Legislative Session
If you anticipate testifying on behalf of these bills and would like information on what to expect, submit the following form and identify the bill(s) for which you intend to provide testimony.
- HB20-1085 Prevention Bill Summary
- HB20-1065 Harm Reduction Bill Summary
- HB20-1017 Criminal Justice Bill Summary
- SB20-007 Treatment Bill Summary
- SB20-028 Recovery Bill Summary
2019 Opioid and Other Substance Use Disorders Study Committee Bills
This summer, a bipartisan committee of state senators and representatives met to consider possible policies to fight the prescription drug misuse and to collect information from community organizations, experts, and citizens.
For more information, including a schedule, list of members, and contact information, go to the committee’s website.
In preparation for the convening of the Study Committee on Opioids and Other Substance Use Disorders in the summer of 2019, the Consortium prepared a form for collecting policy recommendations from stakeholders across the state. As a result, 232 individuals from 47 counties, many who were representing local or statewide organizations, provided 374 policy recommendation for consideration.
This included stakeholders from the fields of healthcare, public health, substance abuse treatment, and criminal justice, as well as from local government, professional associations, and community members.
Policy Requests by Subject Area
The staff of the Consortium organized the submissions and compiled the recommendations into categories. This information helped guide the Study Committee in setting five priority areas for consideration: Prevention, Treatment, Harm Reduction, Criminal Justice, and Recovery